Price
$14.45
Decreased by -0.69%
Dollar volume (20D)
16.22 M
ADR%
6.78
Shares float
74.32 M
Shares short
13.26 M [17.84%]
Shares outstanding
105.20 M
Market cap
1.53 B
Beta
0.37
Price/earnings
N/A
20D range
12.61 17.30
50D range
10.60 30.04
200D range
10.60 38.12

Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders.

Its lead product candidate, EDG-5506, an orally administered small molecule that is in Phase II clinical trials, designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy.

The company develops EDG-7500, a small molecule for the treatment of hypertrophic cardiomyopathy and other severe cardiac disorders that is in Phase I clinical trials.

In addition, it develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders.

The company was incorporated in 2017 and is headquartered in Boulder, Colorado.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
May 7, 25 -0.43
Decreased by -30.30%
-0.42
Decreased by -2.11%
Feb 20, 25 -0.42
Increased by +10.64%
-0.42
Increased by +0.52%
Nov 7, 24 -0.36
Increased by +12.20%
-0.37
Increased by +2.70%
Aug 8, 24 -0.34
Increased by 0.00%
-0.34
May 9, 24 -0.33
Increased by +8.33%
-0.39
Increased by +15.38%
Feb 22, 24 -0.47
Decreased by -51.61%
-0.43
Decreased by -9.30%
Nov 9, 23 -0.41
Decreased by -20.59%
-0.40
Decreased by -2.50%
Aug 10, 23 -0.34
Decreased by -6.25%
-0.40
Increased by +15.00%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Dec 31, 24 0.00
Decreased by -100.00%
-39.66 M
Decreased by -31.58%
Decreased by N/A%
Decreased by N/A%
Sep 30, 24 0.00
Decreased by N/A%
-34.13 M
Decreased by -32.73%
Decreased by N/A%
Decreased by N/A%
Jun 30, 24 0.00
Decreased by N/A%
-31.50 M
Decreased by -46.71%
Decreased by N/A%
Decreased by N/A%
Mar 31, 24 0.00
Decreased by N/A%
-28.52 M
Decreased by -44.57%
Decreased by N/A%
Decreased by N/A%
Dec 31, 23 2.25 M
Increased by +N/A%
-30.14 M
Decreased by -79.95%
Decreased by -1.34 K%
Decreased by N/A%
Sep 30, 23 0.00
Decreased by N/A%
-25.71 M
Decreased by -53.66%
Decreased by N/A%
Decreased by N/A%
Jun 30, 23 0.00
Decreased by N/A%
-21.47 M
Decreased by -37.24%
Decreased by N/A%
Decreased by N/A%
Mar 31, 23 0.00
Decreased by N/A%
-19.73 M
Decreased by -36.13%
Decreased by N/A%
Decreased by N/A%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY